147 related articles for article (PubMed ID: 26577118)
1. Comparison of Survival Outcomes in Women with Unsuspected Uterine Malignancy Diagnosed After Laparotomic Versus Laparoscopic Myomectomy: A National, Population-Based Study.
Yuk JS; Ji HY; Shin JY; Kim LY; Kim SH; Lee JH
Ann Surg Oncol; 2016 Apr; 23(4):1287-93. PubMed ID: 26577118
[TBL] [Abstract][Full Text] [Related]
2. Six-year survival of patients with unsuspected uterine malignancy after laparoscopic versus laparotomic myomectomy: An 11-year national retrospective cohort study.
Yuk JS; Lee JH
Gynecol Oncol; 2018 Oct; 151(1):91-95. PubMed ID: 30146112
[TBL] [Abstract][Full Text] [Related]
3. Seven-year survival analysis in women with unsuspected uterine malignancy after laparotomic versus laparoscopic hysterectomy: A national claim data retrospective cohort study.
Yuk JS; Lee JH
Int J Gynaecol Obstet; 2021 May; 153(2):322-329. PubMed ID: 33448028
[TBL] [Abstract][Full Text] [Related]
4. The incidence of unexpected uterine malignancy in women undergoing hysteroscopic myomectomy or polypectomy: A national population-based study.
Yuk JS; Shin JY; Moon HS; Lee JH
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():12-16. PubMed ID: 29524609
[TBL] [Abstract][Full Text] [Related]
5. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
6. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
[TBL] [Abstract][Full Text] [Related]
7. The Incidence of Unexpected Uterine Malignancy in Women Undergoing Hysterectomy for a Benign Condition: A National Population-Based Study.
Yuk JS; Kim LY; Kim SH; Lee JH
Ann Surg Oncol; 2016 Nov; 23(12):4029-4034. PubMed ID: 27221362
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
[TBL] [Abstract][Full Text] [Related]
9. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
10. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy.
Wright JD; Tergas AI; Cui R; Burke WM; Hou JY; Ananth CV; Chen L; Richards C; Neugut AI; Hershman DL
JAMA Oncol; 2015 Apr; 1(1):69-77. PubMed ID: 26182307
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.
Lee JY; Kim HS; Nam EJ; Kim SW; Kim S; Kim YT
BMC Cancer; 2016 Aug; 16(1):675. PubMed ID: 27553655
[TBL] [Abstract][Full Text] [Related]
12. Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.
Picerno TM; Wasson MN; Gonzalez Rios AR; Zuber MJ; Taylor NP; Hoffman MK; Borowsky ME
Int J Gynecol Cancer; 2016 Jan; 26(1):149-55. PubMed ID: 26332395
[TBL] [Abstract][Full Text] [Related]
13. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
Mettler L; Abdusattarova K; Alkatout I
Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
[TBL] [Abstract][Full Text] [Related]
14. Long-term risk of fibroid recurrence after laparoscopic myomectomy.
Radosa MP; Owsianowski Z; Mothes A; Weisheit A; Vorwergk J; Asskaryar FA; Camara O; Bernardi TS; Runnebaum IB
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():35-9. PubMed ID: 25016181
[TBL] [Abstract][Full Text] [Related]
15. Disseminated leiomyoma cells can be identified following conventional myomectomy.
Sandberg EM; van den Haak L; Bosse T; Jansen FW
BJOG; 2016 Dec; 123(13):2183-2187. PubMed ID: 27533508
[TBL] [Abstract][Full Text] [Related]
16. Effects of laparoscopic versus minilaparotomic myomectomy on uterine leiomyoma: a meta-analysis.
Shen Q; Chen M; Wang Y; Zhou Q; Tao X; Zhang W; Zhu X
J Minim Invasive Gynecol; 2015 Feb; 22(2):177-84. PubMed ID: 25265886
[TBL] [Abstract][Full Text] [Related]
17. A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma.
Gao Z; Li L; Meng Y
PLoS One; 2016; 11(2):e0148050. PubMed ID: 26828206
[TBL] [Abstract][Full Text] [Related]
18. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
19. Morcellation of occult uterine malignancies: an Australian single institution retrospective study.
Tan A; Salfinger S; Tan J; Cohen P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):503-6. PubMed ID: 26314239
[TBL] [Abstract][Full Text] [Related]
20. Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy?
Eltabbakh GH; Shamonki MI; Moody JM; Garafano LL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):329-35. PubMed ID: 10985889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
